Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Sorafenib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Sorafenib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Sorafenib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Sorafenib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Sorafenib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| N-Desmethyl Sorafenib (Pyridine)-N-oxide-d4 | Stable Isotopes | CS-T-100503 | 583840-04-4(unlabelled) | Enquire |
| N-Desmethyl Sorafenib-d4 | Stable Isotopes | CS-T-100504 | Not Available | Enquire |
| Sorafenib N-Oxide 13CD3 | Stable Isotopes | CS-O-46110 | 583840-03-3 (Unlabelled) | Enquire |
| Sorafenib-13C,d3 | Stable Isotopes | CS-O-06977 | 1210608-86-8 | In Stock |
| Sorafenib-d4 | Stable Isotopes | CS-P-08239 | 1207560-07-3 | In Stock |
API
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Sorafenib | API | CS-O-11744 | 284461-73-0 | In Stock |
| Sorafenib Hydrobromide | API | CS-EO-03859 | 1199618-58-0 | Enquire |
| Sorafenib Hydrochloride | API | CS-EO-03858 | 1199618-57-9 | Enquire |
| Sorafenib Tosylate | API | CS-O-31023 | 475207-59-1 | In Stock |
Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 1,3-Bis(4-Chloro-3-(Trifluoromethyl)Phenyl)Urea | Impurity | CS-EO-00218 | 370-50-3 | In Stock |
| 1-Chloro-4-isocyanato-2-(trifluoromethyl)benzene | Impurity | CS-M-27043 | 327-78-6 | In Stock |
| 4-chloro-N-methyl-N-(2-(methylcarbamoyl)pyridine-4-yl)picoli... | Impurity | CS-O-43400 | Not Available | Enquire |
| 4-Deschloro-2-chloro-Sorafenib | Impurity | CS-T-88459 | 1431697-81-2 | In Stock |
| Bis(4-chloro-a,a,a-trifluoro-m-tolyl )sulfone | Impurity | CS-O-44874 | 156218-61-0 | Enquire |
| PAPE-Ethyl carbamate | Impurity | CS-T-93856 | 2206827-12-3 | In Stock |
| phenyl (4-chloro-3-(trifluoromethyl)phenyl)carbamate | Impurity | CS-O-38877 | 871555-75-8 | In Stock |
| Regorafenib Ethyl Carbamate Impurity | Impurity | CS-O-13943 | 18585-06-3 | In Stock |
| Sorafenib Carboxylic Acid Methyl Ester | Impurity | CS-EO-03060 | 573673-43-5 | Enquire |
| Sorafenib EP Impurity E | Impurity | CS-T-92621 | 284670-98-0 | In Stock |
| Sorafenib Impurity 16 | Impurity | CS-EO-03059 | 757251-59-5 | Enquire |
| Sorafenib Impurity 3 | Impurity | CS-ZG-77961 | 1129683-83-5 | In Stock |
| Sorafenib Impurity 40 | Impurity | CS-O-60712 | 2497300-82-8 | Enquire |
| Sorafenib Impurity B | Impurity | CS-EO-02129 | 2514724-45-7 | Enquire |
| Sorafenib Impurity C | Impurity | CS-EO-00035 | 2204442-52-2 | Enquire |
| Sorafenib Impurity J | Impurity | CS-O-47733 | 2206827-18-9 | Enquire |
| Sorafenib phenyl carbamate impurity | Impurity | CS-O-58861 | 1129683-92-6 | In Stock |
| SORAFENIB RELATED COMPOUND 11 | Impurity | CS-O-56795 | 2004659-83-8 | Enquire |
| Sorafenib Related Compound 19 | Impurity | CS-P-06978 | 1012058-77-3 | In Stock |
| Sorafenib Related Compound 21 | Impurity | CS-O-56793 | 2206135-38-6 | Enquire |
| Sorafenib Related Compound 27 Hydrochloride | Impurity | CS-O-59473 | 6144-78-1 (Freebase) | Enquire |
| Sorafenib Related Compound 3 | Impurity | CS-EO-00229 | 1285533-84-7 | In Stock |
| Sorafenib Related Compound 6 | Impurity | CS-EO-00200 | 2206827-14-5 | In Stock |
| Sorafenib related compound 8 | Impurity | CS-O-56792 | 1129683-88-0 | In Stock |
| Sorafenib related compound 9 | Impurity | CS-O-56523 | 343247-69-8 | In Stock |
| 4-(Hydroxyamino)phenol | Impurity | CS-O-41095 | 3505-87-1 | Enquire |
| N-Desmethyl Sorafenib | Impurity | CS-T-88587 | 284461-74-1 | Enquire |
| N-Desmethyl Sorafenib (Pyridine)-N-oxide | Impurity | CS-T-88299 | 583840-04-4 | Enquire |
| N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]a... | Impurity | CS-T-81348 | 1285533-84-7 | Enquire |
| Sorafenib related compound 10 | Impurity | CS-P-06979 | 1012058-78-4 | Enquire |
Intermediate
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (4-Chloro-2-methylphenoxy)acetic Acid | Intermediate | CS-T-12029 | 94-74-6 | In Stock |
| 2-Chlorobenzotrifluoride | Intermediate | CS-O-10806 | 88-16-4 | In Stock |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | Intermediate | CS-O-31780 | 284462-37-9 | Enquire |
| 4-Chloro-N-methyl-2-pyridinecarboxamide | Intermediate | CS-O-31808 | 220000-87-3 | In Stock |
| 4-Chloropyridine-2-carboxamide | Intermediate | CS-M-08751 | 99586-65-9 | In Stock |
Glucuronide
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Sorafenib-β-D-Glucuronide | Glucuronide | CS-T-61387 | 1130164-93-0 | Enquire |
Fine Chemicals
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 2-chloro-3-(trifluoromethyl) phenyl isocyanate | Fine Chemicals | CS-O-37263 | 88330-63-6 | Enquire |
| Methyl (4-chloro-3-trifluoromethylphenyl)carbamate | Fine Chemicals | CS-MM-79648 | 19448-54-5 | Enquire |
Secondary Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Sorafenib Tosylate | Secondary Standards | CS-SS-26570 | 475207-59-1 | Enquire |
Therapeutic
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| p-Toluene sulfonc acid monohydrate | Therapeutic | CS-O-12027 | 6192-52-5 | Enquire |